Gd-Staining Reveals the Efficacy of an Anti-A&[beta] Antibody to Decrease Amyloid Plaque Load in Vivo in a Transgenic Mouse Model of Alzheimer's Disease

Keywords

ability addition agent ages aging aimed allowed allows animal animals anterior anti antibody association bars brain characterized chilly circles clinical comp containing contrast control cortex counted critical date decrease dementia derived described detect detected detection developed developing diagnostics disease drawn early efficacy efforts enable error evaluating evenly falsely forms fourteen free fund gadolinium gradient histological histology humans identified in vivo individual induced injected injection injections inside invasive jack journal lesions load longitudinal major makes manually materials measure measured mice microscopic model monitoring month months mouse neurobiology noise occur others patients pharmacology plaque plaques previously procedure program protocol quantification quantified quantify received recently recognizing record recorded reduced removed represent resolution revealed reveals roses sacrificed sample sections several significantly signs slice slices spaced specifically spots staining stand strategy studied studies tangles targeted targeting tech therapeutic therapies therapy third treated treatments twenty unit validate visible weekly whereas white years